4.7 Review

Green giant-a tiny chloroplast genome with mighty power to produce high-value proteins: history and phylogeny

期刊

PLANT BIOTECHNOLOGY JOURNAL
卷 19, 期 3, 页码 430-447

出版社

WILEY
DOI: 10.1111/pbi.13556

关键词

Biopharmaceuticals; chloroplast genome structure; evolution; carbon capture; COVID-19; enzymes; plastid genetic engineering

资金

  1. NIH [R01 HL 107904, R01 HL 109442, R01 HL 133191]

向作者/读者索取更多资源

The evolutionary history of chloroplasts, from their entrapment by eukaryotic cells 2 billion years ago to their utilization in bioengineering today, has been gradually unveiled. Chloroplasts have shown potential for developing commercial products for everyday use, reflecting their versatility and importance in various fields.
Free-living cyanobacteria were entrapped by eukaryotic cells similar to 2 billion years ago, ultimately giving rise to chloroplasts. After a century of debate, the presence of chloroplast DNA was demonstrated in the 1960s. The first chloroplast genomes were sequenced in the 1980s, followed by similar to 100 vegetable, fruit, cereal, beverage, oil and starch/sugar crop chloroplast genomes in the past three decades. Foreign genes were expressed in isolated chloroplasts or intact plant cells in the late 1980s and stably integrated into chloroplast genomes, with typically maternal inheritance shown in the 1990s. Since then, chloroplast genomes conferred the highest reported levels of tolerance or resistance to biotic or abiotic stress. Although launching products with agronomic traits in important crops using this concept has been elusive, commercial products developed include enzymes used in everyday life from processing fruit juice, to enhancing water absorption of cotton fibre or removal of stains as laundry detergents and in dye removal in the textile industry. Plastid genome sequences have revealed the framework of green plant phylogeny as well as the intricate history of plastid genome transfer events to other eukaryotes. Discordant historical signals among plastid genes suggest possible variable constraints across the plastome and further understanding and mitigation of these constraints may yield new opportunities for bioengineering. In this review, we trace the evolutionary history of chloroplasts, status of autonomy and recent advances in products developed for everyday use or those advanced to the clinic, including treatment of COVID-19 patients and SARS-CoV-2 vaccine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据